141 related articles for article (PubMed ID: 36779324)
1. Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review.
Quintela-Castro FCA; Pereira TSS; Alves DB; Chiepe L; Nascimento LS; Chiepe KCMB; Barcelos RM; Costa BM; Enriquez-Martinez OG; Rossoni JV; Bellettini-Santos T
Nutr Rev; 2023 Sep; 81(10):1310-1320. PubMed ID: 36779324
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women.
Khaw KT; Sharp SJ; Finikarides L; Afzal I; Lentjes M; Luben R; Forouhi NG
BMJ Open; 2018 Mar; 8(3):e020167. PubMed ID: 29511019
[TBL] [Abstract][Full Text] [Related]
4. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
6. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
Massara P; Zurbau A; Glenn AJ; Chiavaroli L; Khan TA; Viguiliouk E; Mejia SB; Comelli EM; Chen V; Schwab U; Risérus U; Uusitupa M; Aas AM; Hermansen K; Thorsdottir I; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
Diabetologia; 2022 Dec; 65(12):2011-2031. PubMed ID: 36008559
[TBL] [Abstract][Full Text] [Related]
7. Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis.
Maraka S; Singh Ospina N; Rodriguez-Gutierrez R; Davidge-Pitts CJ; Nippoldt TB; Prokop LJ; Murad MH
J Clin Endocrinol Metab; 2017 Nov; 102(11):3914-3923. PubMed ID: 28945852
[TBL] [Abstract][Full Text] [Related]
8. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
[TBL] [Abstract][Full Text] [Related]
9. Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy.
Leemaqz SY; Kyinn M; Banks K; Sarkodie E; Goldstein D; Irwig MS
J Clin Lipidol; 2023; 17(1):103-111. PubMed ID: 36473821
[TBL] [Abstract][Full Text] [Related]
10. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men.
Khaw KT; Barrett-Connor E
Arterioscler Thromb; 1991; 11(3):489-94. PubMed ID: 2029491
[TBL] [Abstract][Full Text] [Related]
11. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais JE; Huang X; Zhao JV
Drugs; 2023 Apr; 83(5):403-427. PubMed ID: 36941490
[TBL] [Abstract][Full Text] [Related]
12. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
[TBL] [Abstract][Full Text] [Related]
14. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia.
Quirós C; Patrascioiu I; Mora M; Aranda GB; Hanzu FA; Gómez-Gil E; Godás T; Halperin I
Endocrinol Nutr; 2015 May; 62(5):210-6. PubMed ID: 25790747
[TBL] [Abstract][Full Text] [Related]
15. Waist-to-Height Ratio and Triglycerides/High-Density Lipoprotein Cholesterol Were the Optimal Predictors of Metabolic Syndrome in Uighur Men and Women in Xinjiang, China.
Chen BD; Yang YN; Ma YT; Pan S; He CH; Liu F; Ma X; Fu ZY; Li XM; Xie X; Zheng YY
Metab Syndr Relat Disord; 2015 Jun; 13(5):214-20. PubMed ID: 25781351
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
[TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.
Velho I; Fighera TM; Ziegelmann PK; Spritzer PM
Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin.
Gyllenborg J; Rasmussen SL; Borch-Johnsen K; Heitmann BL; Skakkebaek NE; Juul A
Metabolism; 2001 Aug; 50(8):882-8. PubMed ID: 11474474
[TBL] [Abstract][Full Text] [Related]
19. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
